Finobrate 145mg Tablet
By Finobrate
Rx
10 Tablet in a Strip

Composition
Fenofibrate(145mg)

Manufacturer - Knoll Pharmaceuticals Ltd
M-17, Pharma Tower, Basement & Ground Floor, Badli Industrial Area, New Delhi 110 042

Expires on or after
February, 2027

liver
When it comes to liver health, it is important to note that Finobrate 145mg Tablet may not be safe for individuals with liver disease. Patients with liver issues are advised to avoid using this medication. It is strongly recommended to consult your doctor before starting to use Finobrate 145mg Tablet. Specifically, patients with severe liver disease are advised against the use of this medication. It is crucial to prioritize your liver health and seek medical guidance to ensure the safety of using Finobrate 145mg Tablet.

kidney
Finobrate 145mg Tablet should be used carefully in individuals with kidney disease. A doctor's consultation is advised, as dose adjustments may be required. Avoid usage in cases of severe kidney disease.

alcohol
It is considered unsafe to drink alcohol while taking Finobrate 145mg Tablet.

driving
When taking Finobrate 145mg Tablet, it typically does not impact driving ability. However, individual responses may vary. Monitor your focus and reaction time when driving after taking the medication to ensure safety.

pregnancy
Finobrate 145mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Your doctor will assess the risks versus benefits before recommending its use. Kindly consult your doctor.

breastfeeding
Caution is advised when breastfeeding while using Finobrate 145mg Tablet as it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | PPAR alpha |
Therapeutic Class | - |
Action Class | PPAR alpha agonists (Fibrate) |
₹126.5
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024